2024 -- S 2612 | |
======== | |
LC005078 | |
======== | |
STATE OF RHODE ISLAND | |
IN GENERAL ASSEMBLY | |
JANUARY SESSION, A.D. 2024 | |
____________ | |
A N A C T | |
RELATING TO INSURANCE -- INSURANCE COVERAGE FOR MENTAL ILLNESS AND | |
SUBSTANCE USE DISORDERS | |
| |
Introduced By: Senators Ujifusa, Kallman, Miller, Lauria, Lawson, Valverde, Murray, | |
Date Introduced: March 01, 2024 | |
Referred To: Senate Health & Human Services | |
It is enacted by the General Assembly as follows: | |
1 | SECTION 1. Sections 27-38.2-2 and 27-38.2-3 of the General Laws in Chapter 27-38.2 |
2 | entitled "Insurance Coverage for Mental Illness and Substance Use Disorders" are hereby amended |
3 | to read as follows: |
4 | 27-38.2-2. Definitions. |
5 | For the purposes of this chapter, the following words and terms have the following |
6 | meanings: |
7 | (1) “Financial requirements” means deductibles, copayments, coinsurance, or out-of- |
8 | pocket maximums. |
9 | (2) "Generally accepted standards of mental health and substance use disorder care" means |
10 | standards of care and clinical practice that are generally recognized by health care providers |
11 | practicing in relevant clinical specialties such as psychiatry, psychology, clinical sociology, |
12 | addiction medicine and counseling, and behavioral health treatment. Valid, evidence-based sources |
13 | reflecting generally accepted standards of mental health and substance use disorder care include |
14 | peer-reviewed scientific studies and medical literature, recommendations of nonprofit health care |
15 | provider professional associations and specialty societies, including, but not limited to, patient |
16 | placement criteria and clinical practice guidelines, recommendations of federal government |
17 | agencies, and drug labeling approved by the United States Food and Drug Administration. |
18 | (3) “Group health plan” means an employee welfare benefit plan as defined in 29 U.S.C. § |
| |
1 | 1002(1) to the extent that the plan provides health benefits to employees or their dependents directly |
2 | or through insurance, reimbursement, or otherwise. For purposes of this chapter, a group health |
3 | plan shall not include a plan that provides health benefits directly to employees or their dependents, |
4 | except in the case of a plan provided by the state or an instrumentality of the state. |
5 | (3)(4) “Health insurance plan” means health insurance coverage offered, delivered, issued |
6 | for delivery, or renewed by a health insurer. |
7 | (4)(5) “Health insurers” means all persons, firms, corporations, or other organizations |
8 | offering and assuring health services on a prepaid or primarily expense-incurred basis, including |
9 | but not limited to, policies of accident or sickness insurance, as defined by chapter 18 of this title; |
10 | nonprofit hospital or medical service plans, whether organized under chapter 19 or 20 of this title |
11 | or under any public law or by special act of the general assembly; health maintenance organizations, |
12 | or any other entity that insures or reimburses for diagnostic, therapeutic, or preventive services to |
13 | a determined population on the basis of a periodic premium. Provided, this chapter does not apply |
14 | to insurance coverage providing benefits for: |
15 | (i) Hospital confinement indemnity; |
16 | (ii) Disability income; |
17 | (iii) Accident only; |
18 | (iv) Long-term care; |
19 | (v) Medicare supplement; |
20 | (vi) Limited benefit health; |
21 | (vii) Specific disease indemnity; |
22 | (viii) Sickness or bodily injury or death by accident or both; and |
23 | (ix) Other limited benefit policies. |
24 | (6) "Medically necessary treatment of a mental health or substance use disorder" means a |
25 | service or product addressing the specific needs of that patient, for the purpose of screening, |
26 | preventing, diagnosing, managing or treating an illness, injury, condition, or its symptoms, |
27 | including minimizing the progression of an illness, injury, condition, or its symptoms, in a manner |
28 | that is all of the following: |
29 | (i) In accordance with the generally accepted standards of mental health and substance use |
30 | disorder care; |
31 | (ii) Clinically appropriate in terms of type, frequency, extent, site, and duration; and |
32 | (iii) Not primarily for the economic benefit of the insurer, purchaser, or for the convenience |
33 | of the patient, treating physician, or other health care provider. |
34 | (7) "Mental health and substance use disorders" means a mental health condition or |
| LC005078 - Page 2 of 9 |
1 | substance use disorder that falls under any of the diagnostic categories listed in the mental and |
2 | behavioral disorders chapter of the most recent edition of the World Health Organization's |
3 | International Statistical Classification of Diseases and Related Health Problems, or that is listed in |
4 | the most recent version of the American Psychiatric Association's Diagnostic and Statistical |
5 | Manual of Mental Disorders. Changes in terminology, organization, or classification of mental |
6 | health and substance use disorders in future versions of the American Psychiatric Association's |
7 | Diagnostic and Statistical Manual of Mental Disorders or the World Health Organization's |
8 | International Statistical Classification of Diseases and Related Health Problems shall not affect the |
9 | conditions covered by this chapter as long as a condition is commonly understood to be a mental |
10 | health or substance use disorder by health care providers practicing in relevant clinical specialties. |
11 | (5) “Mental health or substance use disorder” means any mental disorder and substance |
12 | use disorder that is listed in the most recent revised publication or the most updated volume of |
13 | either the Diagnostic and Statistical Manual of Mental Disorders (DSM) published by the American |
14 | Psychiatric Association or the International Classification of Disease Manual (ICO) published by |
15 | the World Health Organization; provided, that tobacco and caffeine are excluded from the |
16 | definition of “substance” for the purposes of this chapter. |
17 | (6)(8) “Non-quantitative treatment limitations” means: (i) Medical management standards; |
18 | (ii) Formulary design and protocols; (iii) Network tier design; (iv) Standards for provider admission |
19 | to participate in a network; (v) Reimbursement rates and methods for determining usual, customary, |
20 | and reasonable charges; and (vi) Other criteria that limit scope or duration of coverage for services |
21 | in the treatment of mental health and substance use disorders, including restrictions based on |
22 | geographic location, facility type, and provider specialty. |
23 | (7)(9) “Quantitative treatment limitations” means numerical limits on coverage for the |
24 | treatment of mental health and substance use disorders based on the frequency of treatment, number |
25 | of visits, days of coverage, days in a waiting period, or other similar limits on the scope or duration |
26 | of treatment. |
27 | (10) "Utilization review" means either of the following: |
28 | (i) Prospectively, retrospectively, or concurrently reviewing and approving, modifying, |
29 | delaying, or denying, based, in whole or in part, on medical necessity, requests by health care |
30 | providers, insureds, or their authorized representatives for coverage of health care services prior to, |
31 | retrospectively or concurrent with the provision of health care services to insureds; or |
32 | (ii) Evaluating the medical necessity, appropriateness, level of care, service intensity, |
33 | efficacy, or efficiency of health care services, benefits, procedures, or settings, under any |
34 | circumstances, to determine whether a health care service or benefit subject to a medical necessity |
| LC005078 - Page 3 of 9 |
1 | coverage requirement in an insurance policy is covered as medically necessary for an insured. |
2 | (11) "Utilization review criteria" means any criteria, standards, protocols, or guidelines |
3 | used by an insurer to conduct utilization review. |
4 | 27-38.2-3. Medical necessity and appropriateness of treatment. |
5 | (a) Upon request of the reimbursing health insurers, all providers of treatment of mental |
6 | illness shall furnish medical records or other necessary data that substantiates that initial or |
7 | continued treatment is at all times medically necessary and appropriate. When the provider cannot |
8 | establish the medical necessity and/or appropriateness of the treatment modality being provided, |
9 | neither the health insurer nor the patient shall be obligated to reimburse for that period or type of |
10 | care that was not established. The exception to the preceding can only be made if the patient has |
11 | been informed of the provisions of this subsection and has agreed in writing to continue to receive |
12 | treatment at his or her own expense. Every insurance policy issued, amended, or renewed on or |
13 | after January 1, 2025, that provides hospital, medical, or surgical coverage shall provide coverage |
14 | for medically necessary treatment of mental health and substance use disorders. |
15 | (b) The health insurers, when making the determination of medically necessary and |
16 | appropriate treatment, must do so in a manner consistent with that used to make the determination |
17 | for the treatment of other diseases or injuries covered under the health insurance policy or |
18 | agreement. An insurer shall not limit benefits or coverage for chronic or pervasive mental health |
19 | and substance use disorders to short-term or acute treatment at any level of care placement. |
20 | (c) Any subscriber who is aggrieved by a denial of benefits provided under this chapter |
21 | may appeal a denial in accordance with the rules and regulations promulgated by the department |
22 | of health pursuant to chapter 17.12 [repealed] of title 23. All medical necessity determinations made |
23 | by the insurer concerning service intensity, level of care placement, continued stay, and transfer or |
24 | discharge of insureds diagnosed with mental health and substance use disorders shall be conducted |
25 | in accordance with the requirements of § 27-38.2-7. |
26 | (d) An insurer that authorizes a specific type of treatment by a provider pursuant to this |
27 | section shall not rescind or modify the authorization after the provider renders the health care |
28 | service in good faith and pursuant to this authorization for any reason, including, but not limited |
29 | to, the insurer's subsequent rescission, cancellation, or modification of the insured's or |
30 | policyholder's contract, or the insurer's subsequent determination that it did not make an accurate |
31 | determination of the insured's or policyholder's eligibility. This section shall not be construed to |
32 | expand or alter the benefits available to the insured or policyholder under an insurance policy. |
33 | (e) If services for the medically necessary treatment of a mental health or substance use |
34 | disorder are not available in network within the geographic and timeliness access standards set by |
| LC005078 - Page 4 of 9 |
1 | law or regulation, the insurer shall arrange coverage to ensure the delivery of medically necessary |
2 | out-of-network services and any medically necessary follow-up services that, to the maximum |
3 | extent possible, meet those geographic and timely access standards. As used in this subsection, to |
4 | "arrange coverage to ensure the delivery of medically necessary out-of-network services" includes, |
5 | but is not limited to, providing services to secure medically necessary out-of network options that |
6 | are available to the insured within geographic and timely access standards. The insured shall pay |
7 | no more in total for benefits rendered than the cost sharing that the insured would pay for the same |
8 | covered services received from an in-network provider. |
9 | (f) An insurer shall not limit benefits or coverage for medically necessary services on the |
10 | basis that those services should be or could be covered by a public entitlement program, including, |
11 | but not limited to, special education or an individualized education program, Medicaid, Medicare, |
12 | Supplemental Security Income, or Social Security Disability Insurance, and shall not include or |
13 | enforce a contract term that excludes otherwise covered benefits on the basis that those services |
14 | should be or could be covered by a public entitlement program. |
15 | (g) An insurer shall not adopt, impose, or enforce terms in its policies or provider |
16 | agreements, in writing or in operation, that undermine, alter, or conflict with the requirements of |
17 | this section. |
18 | (h) If the insurance commissioner determines that an insurer has violated this section, the |
19 | commissioner may, after appropriate notice and opportunity for hearing, by order, assess a civil |
20 | penalty not to exceed five thousand dollars ($5,000) for each violation, or, if a violation was willful, |
21 | a civil penalty not to exceed ten thousand dollars ($10,000) for each violation. The civil penalties |
22 | available to the commissioner pursuant to this section are not exclusive and may be sought and |
23 | employed in combination with any other remedies available to the commissioner. |
24 | SECTION 2. Chapter 27-38.2 of the General Laws entitled "Insurance Coverage for Mental |
25 | Illness and Substance Use Disorders" is hereby amended by adding thereto the following sections: |
26 | 27-38.2-7. Medical necessity determinations shall follow generally accepted |
27 | standards. |
28 | (a) An insurer that provides hospital, medical, or surgical coverage shall base any medical |
29 | necessity determination or the utilization review criteria that the insurer, and any entity acting on |
30 | the insurer's behalf, applies to determine the medical necessity of health care services and benefits |
31 | for the diagnosis, prevention, and treatment of mental health and substance use disorders on current |
32 | generally accepted standards of mental health and substance use disorder care as defined in § 27- |
33 | 38.2-2. All denials and appeals shall be reviewed by a professional with the same level of education |
34 | and experience of the provider requesting the authorization. |
| LC005078 - Page 5 of 9 |
1 | (b) In conducting an utilization review of all covered health care services and benefits for |
2 | the diagnosis, prevention, and treatment of mental health and substance use disorders in children, |
3 | adolescents, and adults, an insurer shall apply the level of care placement criteria and practice |
4 | guidelines set forth in the most recent versions of such criteria and practice guidelines, developed |
5 | by the nonprofit professional association for the relevant clinical specialty. |
6 | (c) In conducting an utilization review involving level of care placement decisions or any |
7 | other patient care decisions that are within the scope of the sources specified in subsection (b) of |
8 | this section, an insurer shall not apply different, additional, conflicting, or more restrictive |
9 | utilization review criteria than the criteria and guidelines set forth in those sources. For all level of |
10 | care placement decisions, the insurer shall authorize placement at the level of care consistent with |
11 | the insured's score using the relevant level of care placement criteria and guidelines as specified in |
12 | subsection (b) of this section. If that level of placement is not available, the insurer shall authorize |
13 | the next higher level of care. In the event of disagreement, the insurer shall provide full detail of its |
14 | scoring using the relevant level of care placement criteria and guidelines as specified in subsection |
15 | (b) of this section, to the provider of the service. |
16 | (d) To ensure the proper use of the criteria described in subsection (b) of this section, every |
17 | insurer shall do all of the following: |
18 | (1) Sponsor a formal education program by nonprofit clinical specialty associations to |
19 | educate the insurer's staff, including any third parties contracted with the insurer to review claims, |
20 | conduct utilization reviews, or make medical necessity determinations about the clinical review |
21 | criteria; |
22 | (2) Make the education program available to other stakeholders, including the insurer's |
23 | participating providers and covered lives; |
24 | (3) Provide, at no cost, the clinical review criteria and any training material or resources to |
25 | providers and insured patients; |
26 | (4) Track, identify, and analyze how the clinical review criteria are used to certify care, |
27 | deny care, and support the appeals process; |
28 | (5) Conduct interrater reliability testing to ensure consistency in utilization review decision |
29 | making covering how medical necessity decisions are made. This assessment shall cover all aspects |
30 | of utilization review as defined in § 27-38.2-2; |
31 | (6) Run interrater reliability reports about how the clinical guidelines are used in |
32 | conjunction with the utilization management process and parity compliance activities; and |
33 | (7) Achieve interrater reliability pass rates of at least ninety percent (90%) and, if this |
34 | threshold is not met, immediately provide for the remediation of poor interrater reliability and |
| LC005078 - Page 6 of 9 |
1 | interrater reliability testing for all new staff before they can conduct an utilization review without |
2 | supervision. |
3 | (e) This section applies to all health care services and benefits for the diagnosis, prevention, |
4 | and treatment of mental health and substance use disorders covered by an insurance policy, |
5 | including prescription drugs. |
6 | (f) This section applies to an insurer that covers hospital, medical, or surgical expenses and |
7 | conducts an utilization review as defined in § 27-38.2-2, and any entity or contracting provider that |
8 | performs utilization review or utilization management functions on an insurer's behalf. |
9 | (g) If the insurance commissioner determines that an insurer has violated this section, the |
10 | commissioner may, after appropriate notice and opportunity for hearing, by order, assess a civil |
11 | penalty not to exceed five thousand dollars ($5,000) for each violation, or, if a violation was willful, |
12 | a civil penalty not to exceed ten thousand dollars ($10,000) for each violation. The civil penalties |
13 | available to the commissioner pursuant to this section are not exclusive and may be sought and |
14 | employed in combination with any other remedies available to the commissioner. |
15 | (h) An insurer shall not adopt, impose, or enforce terms in its policies or provider |
16 | agreements, in writing or in operation, that undermine, alter, or conflict with the requirements of |
17 | this section. |
18 | 27-38.2-8. Discretionary clauses prohibited. |
19 | (a) If an insurance contract offered, issued, delivered, amended, or renewed on or after |
20 | January 1, 2025, contains a provision that reserves discretionary authority to the insurer, or an agent |
21 | of the insurer, to determine eligibility for benefits or coverage, to interpret the terms of the contract, |
22 | or to provide standards of interpretation or review that are inconsistent with the laws of this state, |
23 | that provision is void and unenforceable. |
24 | (b) For purposes of this section, the term "discretionary authority" means a contract |
25 | provision that has the effect of conferring discretion on an insurer or other claims administrator to |
26 | determine entitlement to benefits or interpret contract language that, in turn, could lead to a |
27 | deferential standard of review by a reviewing court. |
28 | (c) This section does not prohibit an insurer from including a provision in a contract that |
29 | informs an insured that, as part of its routine operations, the plan applies the terms of its contracts |
30 | for making decisions, including making determinations regarding eligibility, receipt of benefits and |
31 | claims, or explaining policies, procedures, and processes, as long as the provision could not give |
32 | rise to a deferential standard of review by a reviewing court. |
33 | 27-38.2-9. Severability clause. |
34 | The provisions of this chapter are severable. If any provision of this chapter or its |
| LC005078 - Page 7 of 9 |
1 | application is held invalid, that invalidity shall not affect other provisions or applications that can |
2 | be given effect without the invalid provision or application. |
3 | SECTION 3. This act shall take effect upon passage. |
======== | |
LC005078 | |
======== | |
| LC005078 - Page 8 of 9 |
EXPLANATION | |
BY THE LEGISLATIVE COUNCIL | |
OF | |
A N A C T | |
RELATING TO INSURANCE -- INSURANCE COVERAGE FOR MENTAL ILLNESS AND | |
SUBSTANCE USE DISORDERS | |
*** | |
1 | This act would require that any insurance contract issued, amended or renewed on or after |
2 | January 1, 2025, that provides hospital, medical or surgical coverage shall provide coverage for |
3 | medically necessary treatment of mental health or substance use disorders. This act would further |
4 | provide that out-of-network coverage shall be provided if in-network coverage is not available for |
5 | medically necessary treatment of a mental health or substance use disorder. This act would further |
6 | prohibit an insurer from limiting coverage for medically necessary services solely on the basis that |
7 | such services would be covered by a public entitlement program. |
8 | This act would take effect upon passage. |
======== | |
LC005078 | |
======== | |
| LC005078 - Page 9 of 9 |